Inflation Reduction Act Research Series: Medicare Enrollees' Use and Out-of-Pocket Expenditures for Drugs Selected for Negotiation under the Medicare Drug Price Negotiation Program
Link
Description
Provides an overview of the Medicare Drug Price Negotiation Program established by the Inflation Reduction Act. Examines prescription drug use and out-of-pocket spending by Medicare Part D enrollees in calendar year 2022 for each of the first 10 drugs selected for price negotiations, which will be applicable in 2026. Includes data on the demographic characteristics of Medicare Part D enrollees taking each drug, including urban-rural status, as well as the number of enrollees and mean out-of-pocket spending on each drug by state.
Date
09/2023
Type
Document
Organization
HHS Office of the Assistant Secretary for Planning and Evaluation
Tagged as
Healthcare business and finance · Medicare · Pharmacy and prescription drugs · Rural-urban differences · State-by-state data · Statistics and data · State-by-state
Related Content
Organizations (1)
- HHS Office of the Assistant Secretary for Planning and Evaluation, view details